Treasurer of the State of North Carolina’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.69M | Sell |
45,238
-400
| -0.9% | -$50.3K | 0.02% | 602 |
|
|
2025
Q1 | $5.05M | Sell |
45,638
-21,860
| -32% | -$2.42M | 0.02% | 584 |
|
|
2024
Q4 | $9.21M | Sell |
67,498
-1,070
| -2% | -$146K | 0.04% | 424 |
|
|
2024
Q3 | $7.9M | Sell |
68,568
-1,548
| -2% | -$178K | 0.03% | 479 |
|
|
2024
Q2 | $9.65M | Buy |
70,116
+1,094
| +2% | +$151K | 0.04% | 393 |
|
|
2024
Q1 | $9.52M | Buy |
69,022
+203
| +0.3% | +$28K | 0.04% | 397 |
|
|
2023
Q4 | $9.07M | Buy |
68,819
+576
| +0.8% | +$75.9K | 0.04% | 389 |
|
|
2023
Q3 | $7.68M | Sell |
68,243
-845
| -1% | -$95.1K | 0.04% | 407 |
|
|
2023
Q2 | $6.52M | Buy |
69,088
+400
| +0.6% | +$37.7K | 0.03% | 462 |
|
|
2023
Q1 | $6.95M | Buy |
68,688
+240
| +0.4% | +$24.3K | 0.04% | 437 |
|
|
2022
Q4 | $8.18M | Buy |
68,448
+8,120
| +13% | +$970K | 0.05% | 386 |
|
|
2022
Q3 | $6.41M | Buy |
60,328
+20,240
| +50% | +$2.15M | 0.04% | 418 |
|
|
2022
Q2 | $3.91M | Buy |
40,088
+5,629
| +16% | +$549K | 0.02% | 575 |
|
|
2022
Q1 | $3.23M | Buy |
34,459
+545
| +2% | +$51.1K | 0.02% | 627 |
|
|
2021
Q4 | $2.89M | Sell |
33,914
-13,496
| -28% | -$1.15M | 0.02% | 692 |
|
|
2021
Q3 | $4.55M | Buy |
47,410
+749
| +2% | +$71.8K | 0.03% | 535 |
|
|
2021
Q2 | $4.54M | Sell |
46,661
-1,840
| -4% | -$179K | 0.03% | 538 |
|
|
2021
Q1 | $4.72M | Sell |
48,501
-3,060
| -6% | -$298K | 0.03% | 518 |
|
|
2020
Q4 | $4.94M | Buy |
51,561
+350
| +0.7% | +$33.5K | 0.03% | 483 |
|
|
2020
Q3 | $4.92M | Sell |
51,211
-6,440
| -11% | -$619K | 0.04% | 422 |
|
|
2020
Q2 | $7.03M | Sell |
57,651
-5,845
| -9% | -$713K | 0.06% | 310 |
|
|
2020
Q1 | $5.5M | Buy |
63,496
+16,185
| +34% | +$1.4M | 0.05% | 330 |
|
|
2019
Q4 | $5.09M | Sell |
47,311
-2,510
| -5% | -$270K | 0.04% | 314 |
|
|
2019
Q3 | $4.49M | Sell |
49,821
-11,600
| -19% | -$1.05M | 0.04% | 321 |
|
|
2019
Q2 | $5.19M | Buy |
61,421
+3,450
| +6% | +$291K | 0.03% | 463 |
|
|
2019
Q1 | $5.11M | Buy |
57,971
+5,939
| +11% | +$523K | 0.03% | 444 |
|
|
2018
Q4 | $3.72M | Buy |
52,032
+2,958
| +6% | +$211K | 0.03% | 509 |
|
|
2018
Q3 | $6.04M | Buy |
49,074
+28,991
| +144% | +$3.57M | 0.04% | 407 |
|
|
2018
Q2 | $1.97M | Buy |
20,083
+11,848
| +144% | +$1.16M | 0.02% | 591 |
|
|
2018
Q1 | $683K | Buy |
+8,235
| New | +$683K | 0.02% | 734 |
|